Next Generation Sequencing (NGS) Informatics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Laboratory Information Management Systems (LIMS), By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others), By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions), By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2024-2028

Market Size (2022)

USD 1498.02 million

CAGR (2023-2028)

9.23%

Fastest Growing Segment

Genetic Screening

Largest Market

North America

Global Next Generation Sequencing (NGS) Informatics Market is anticipated to observe an impressive growth during the forecast period, 2024-2028 owing to growing prevalence of cancer and increase in clinical applications for Next Generation Sequencing (NGS). According to Global Cancer Observatory, in 2020, around 19,292,789 new cancer cases were reported worldwide. Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer and Stomach Cancer were the most prevalent types of cancer cases reported in 2020. Additionally, increase in number of samples for DNA sequencing, reduced cost of DNA sequencing with the use of Next Generation Sequencing (NGS) informatics, various government initiatives, rising clinical applications, substitution of Microarray technology by Next Generation Sequencing (NGS) are other factors contributing to market growth.

The growing prevalence of new viral diseases has significantly increased the demand for Next Generation Sequencing (NGS) Informatics market. Additionally, growing research & development activities being initiated by various governments and pharmaceutical & biotechnology companies across the globe is further expected to create lucrative opportunities for the growth of Next Generation Sequencing (NGS) Informatics market in the coming years. In 2021, the research & development expenditure in the pharmaceutical industry across the globe was around USD238 billion.



Rise in Prevalence of Chronic Diseases

Globally, the cancer is the leading cause of death. According to World Health Organization, around 50,550,287 cases of cancer have been reported worldwide in the last five years. This is brought due to the presence of physical carcinogens like ultraviolet and ionising radiation, chemical carcinogens like asbestos, tobacco smoke, alcohol, aflatoxin (a food contaminant), and arsenic (a drinking water contaminant), and biological carcinogens like parasite infections and unhealthy lifestyle choices. A major issue in healthcare nowadays is cancer. The demand for novel cancer therapies is anticipated to fuel the expansion of the global Next Generation Sequencing (NGS) Informatics market.

Similarly, the increasing prevalence of new viral diseases such as HIV, Human Papillomavirus and Tuberculosis which are deadly and require a potential treatment is further expected to drive the growth of global Next Generation Sequencing (NGS) Informatics Market. As of 2021, globally around 38.4 million people were living with HIV.

 

Increase in Clinical Research for Next Generation Sequencing (NGS)

Clinical research is medical research constituting two components: observational studies, clinical trials. The clinical research activities result in taking care of the human health by identifying the viral genome sequence through Next Generation Sequencing (NGS). The Next Generation Sequencing (NGS) technique plays a vital role in studying the mutations in the viral genome and their impact on human health as well. According to a research article published in Clinical OMICS, 2020, approximately 84,000 viral genomic sequences of the coronavirus have been uploaded to the Global Initiative to Share All Influenza Data (GISAID). Additionally, the application like whole genome and transcriptome sequencing, metagenomics, etc. is used for the characterization of different microbial samples which in turn is expected to fuel the growth of Global Next Generation Sequencing (NGS) Informatics Market.

 


Download Free Sample Report

Substitution of DNA Microarray Technology

With recent advancements and a radical decline in sequencing costs, the popularity of next generation sequencing (Next Generation Sequencing (NGS)) has skyrocketed. As costs become less prohibitive and methods become simpler and more widespread, researchers are choosing Next Generation Sequencing (NGS) over microarrays for more of their genomic applications. Additionally, Next Generation Sequencing (NGS) has the potential to offer even higher resolution and a more comprehensive view of the genome.

This clearly indicates that a lot of R&D is being done across the globe for utilizing Next Generation Sequencing (NGS) sequencing for the treatment of human health, thereby supporting the growth of global Next Generation Sequencing (NGS) Informatics Market.

 

Market Segmentation

Global Next Generation Sequencing (NGS) Informatics Market can be segmented based on products & services, application, end user, region and competitional landscape. Based on products & services, the market can be categorized into storage and computing tools, commercial data analysis, data interpretation, and reporting tools, Next Generation Sequencing (NGS), laboratory information management systems (LIMS). Based on application, the market can be fragmented into drug discovery, genetic screening, disease diagnosis, and others. Based on end user, the market can be divided into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, academic and research institutions.

 

Company Profiles

Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., SOPHiA GENETICS SA, Precigen, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Eagle Genomics Limited, BGI Genomics Co., Ltd. are some of the key players operating in the Global Next Generation Sequencing (NGS) Informatics Market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

Products & Services

Application

End User

Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; Germany; France; United Kingdom; Spain; Italy; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa; Turkey; Egypt

Key companies profiled

Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., SOPHiA GENETICS SA, Precigen, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Eagle Genomics Limited, BGI Genomics Co., Ltd.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:
In this report, Global Next Generation Sequencing (NGS) Informatics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Next Generation Sequencing (NGS) Informatics Market, By Products & Services:

o    Storage and Computing Tools

o    Commercial Data Analysis

o    Data Interpretation, and Reporting Tools

o    Next Generation Sequencing (NGS)

o    Laboratory Information Management Systems (LIMS)

·         Next Generation Sequencing (NGS) Informatics Market, By Application:

o    Drug Discovery

o    Genetic Screening

o    Disease Diagnosis

o    Others

·         Next Generation Sequencing (NGS) Informatics Market, By End User:

o    Hospitals and Diagnostic Centers

o    Pharmaceutical and Biotechnology Companies

o    Academic and Research Institutions

·         Next Generation Sequencing (NGS) Informatics Market, By Region:

o    North America

§  United States

§  Canada

§  Mexico

o    Europe

§  Germany

§  France

§  United Kingdom

§  Italy

§  Spain

o    Asia-Pacific

§  China

§  Japan

§  India

§  South Korea

§  Australia

o    South America

§  Brazil

§  Argentina

§  Colombia

o    Middle East & Africa

§  UAE

§  Saudi Arabia

§  South Africa

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Next Generation Sequencing (NGS) Informatics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Next Generation Sequencing (NGS) Informatics Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.   By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))

5.2.2.   By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)

5.2.3.   By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)

5.2.4.   By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)

5.2.5.     By Company (2022)

5.3.  Market Map

5.3.1.     By Products & Services

5.3.2.     By Application

5.3.3.     By End User

5.3.4.     By Region

6.    North America Next Generation Sequencing (NGS) Informatics Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Products & Services

6.2.2.     By Application

6.2.3.     By End User

6.2.4.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Next Generation Sequencing (NGS) Informatics Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.               By Products & Services

6.3.1.2.2.               By Application

6.3.1.2.3.               By End User

6.3.2.     Canada Next Generation Sequencing (NGS) Informatics Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Products & Services

6.3.2.2.2.             By Application

6.3.2.2.3.             By End User

6.3.3.      Mexico Next Generation Sequencing (NGS) Informatics Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Products & Services

6.3.3.2.2.             By Application

6.3.3.2.3.             By End User

7.    Europe Next Generation Sequencing (NGS) Informatics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Products & Services

7.2.2.     By Application

7.2.3.     By End User

7.2.4.     By Country

7.3.  Europe: Country Analysis

7.3.1.     Germany Next Generation Sequencing (NGS) Informatics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Products & Services

7.3.1.2.2.             By Application

7.3.1.2.3.             By End User

7.3.1.2.4.             By Country

7.3.2.     France Next Generation Sequencing (NGS) Informatics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.               By Products & Services

7.3.2.2.2.               By Application

7.3.2.2.3.               By End User

7.3.3.     United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Products & Services

7.3.3.2.2.             By Application

7.3.3.2.3.             By End User

7.3.4.     Italy Next Generation Sequencing (NGS) Informatics Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Products & Services

7.3.4.2.2.             By Application

7.3.4.2.3.             By End User

7.3.5.     Spain Next Generation Sequencing (NGS) Informatics Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.               By Products & Services

7.3.5.2.2.               By Application

7.3.5.2.3.               By End User

8.    Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Products & Services

8.2.2.     By Application

8.2.3.     By End User

8.2.4.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Next Generation Sequencing (NGS) Informatics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Products & Services

8.3.1.2.2.             By Application

8.3.1.2.3.             By End User

8.3.2.     Japan Next Generation Sequencing (NGS) Informatics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Products & Services

8.3.2.2.2.             By Application

8.3.2.2.3.             By End User

8.3.3.     India Next Generation Sequencing (NGS) Informatics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Products & Services

8.3.3.2.2.             By Application

8.3.3.2.3.             By End User

8.3.4.     South Korea Next Generation Sequencing (NGS) Informatics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.               By Products & Services

8.3.4.2.2.               By Application

8.3.4.2.3.               By End User

8.3.5.     Australia Next Generation Sequencing (NGS) Informatics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Products & Services

8.3.5.2.2.             By Application

8.3.5.2.3.             By End User

9.    South America Next Generation Sequencing (NGS) Informatics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Products & Services

9.2.2.     By Application

9.2.3.     By End User

9.2.4.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Next Generation Sequencing (NGS) Informatics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Products & Services

9.3.1.2.2.             By Application

9.3.1.2.3.             By End User

9.3.2.     Argentina Next Generation Sequencing (NGS) Informatics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.               By Products & Services

9.3.2.2.2.               By Application

9.3.2.2.3.               By End User

9.3.3.     Colombia Next Generation Sequencing (NGS) Informatics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Products & Services

9.3.3.2.2.             By Application

9.3.3.2.3.             By End User

10.  Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Products & Services

10.2.2.  By Application

10.2.3.  By End User

10.2.4.  By Country

10.3.              MEA: Country Analysis

10.3.1.  UAE Next Generation Sequencing (NGS) Informatics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Products & Services

10.3.1.2.2.           By Application

10.3.1.2.3.           By End User

10.3.2.  Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.             By Products & Services

10.3.2.2.2.             By Application

10.3.2.2.3.             By End User

10.3.3.  South Africa Next Generation Sequencing (NGS) Informatics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Products & Services

10.3.3.2.2.           By Application

10.3.3.2.3.           By End User

10.3.4.  Turkey Next Generation Sequencing (NGS) Informatics Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Products & Services

10.3.4.2.2.           By Application

10.3.5.  Egypt Next Generation Sequencing (NGS) Informatics Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.           By Products & Services

10.3.5.2.2.           By Application

10.3.5.2.3.           By End User

11.  Market Dynamics

11.1.              Drivers

11.1.1.  Rise in Prevalence of Chronic Diseases

11.1.2.  Increase in clinical research for Next Generation Sequencing (NGS)

11.1.3.  Substitution of DNA Microarray Technology

12.  Challenges

12.1.1.  Lack of trained clinical personnel for conducting Next Generation Sequencing (NGS) experiments

12.1.2.  Poor reimbursement rates for Next Generation Sequencing (NGS) across the globe

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Business Overview

14.2.              Product Offerings

14.3.              Recent Developments

14.4.              Financials (As Reported)

14.5.              Key Personnel

14.5.1.                Abbott Laboratories, Inc.

14.5.2.                F. Hoffmann-La Roche Ltd.

14.5.3.                PerkinElmer, Inc.

14.5.4.                SOPHiA GENETICS SA

14.5.5.                Precigen, Inc.

14.5.6.                QIAGEN N.V.

14.5.7.                Illumina, Inc.

14.5.8.                Agilent Technologies, Inc.

14.5.9.                Eagle Genomics Limited

14.5.10.             BGI Genomics Co., Ltd.

15. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Global Next Generation Sequencing (NGS) Informatics Market is expected to grow at impressive rate on account of increasing number of clinical applications by Next Generation Sequencing (NGS), reduced cost of DNA sequencing with the use of Next Generation Sequencing (NGS) informatics, various government initiatives, substitution of Microarray technology by Next Generation Sequencing (NGS).

down-arrow

North America will be the fastest growing region due to the growing prevalence of cancer and increasing research & development activities for the identification and characterization of viral genome.

down-arrow

Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., SOPHiA GENETICS SA, Precigen, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Eagle Genomics Limited, BGI Genomics Co., Ltd.

down-arrow

Lack of trained clinical personnel for conducting Next Generation Sequencing (NGS) experiments and performing data analysis, and privacy challenges are expected to lead to concerns surrounding data privacy among people and hinder the growth of the global Next Generation Sequencing (NGS) Informatics market during the forecast period.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Next Generation Sequencing (NGS) Informatics Market is expected to be dominated by the commercial data analysis tools through 2028

Apr, 2023

Rising prevalence of cancer and reduction in mass scale genetic testing cost is significantly expected to drive the growth of Global Next Generation Sequencing (NGS) Informatics Market during the for

Why Choose Us